- Home
- IPA vs TXMD Comparison
IPA vs TXMD Comparison
Compare IPA & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- TXMD
- Stock Information
- Founded
- IPA 1983
- TXMD 2008
- Country
- IPA Canada
- TXMD United States
- Employees
- IPA N/A
- TXMD N/A
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- IPA Health Care
- TXMD Health Care
- Exchange
- IPA Nasdaq
- TXMD Nasdaq
- Market Cap
- IPA 18.9M
- TXMD 17.9M
- IPO Year
- IPA 2017
- TXMD N/A
- Fundamental
- Price
- IPA $0.44
- TXMD $1.41
- Analyst Decision
- IPA Strong Buy
- TXMD
- Analyst Count
- IPA 2
- TXMD 0
- Target Price
- IPA $6.00
- TXMD N/A
- AVG Volume (30 Days)
- IPA 1.1M
- TXMD 17.4K
- Earning Date
- IPA 12-12-2024
- TXMD 11-12-2024
- Dividend Yield
- IPA N/A
- TXMD N/A
- EPS Growth
- IPA N/A
- TXMD N/A
- EPS
- IPA N/A
- TXMD N/A
- Revenue
- IPA $17,441,886.00
- TXMD $1,596,000.00
- Revenue This Year
- IPA $4.33
- TXMD $605.07
- Revenue Next Year
- IPA $35.64
- TXMD $1.11
- P/E Ratio
- IPA N/A
- TXMD N/A
- Revenue Growth
- IPA 11.21
- TXMD N/A
- 52 Week Low
- IPA $0.35
- TXMD $1.38
- 52 Week High
- IPA $2.60
- TXMD $3.07
- Technical
- Relative Strength Index (RSI)
- IPA 40.98
- TXMD 19.09
- Support Level
- IPA $0.40
- TXMD $1.47
- Resistance Level
- IPA $0.53
- TXMD $1.58
- Average True Range (ATR)
- IPA 0.07
- TXMD 0.06
- MACD
- IPA 0.00
- TXMD -0.01
- Stochastic Oscillator
- IPA 37.76
- TXMD 13.23
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.